监管与产业动态· FiercePharma·· 21 天前评分13
Fierce Pharma Asia—AZ’s $2B bet on ivonescimab; Novo buys Hengrui GLP-1; Merck doubles down on KRAS - Fierce Pharma
Fierce Pharma Asia—AZ’s $2B bet on ivonescimab; Novo buys Hengrui GLP-1; Merck doubles down on KRAS - Fierce Pharma
来源：监管与产业动态 · news.google.com